Correction to the PRoFESS Trial paper by Diener et al. (Cerebrovasc Dis 2007;23:368-80

Journal article

Peer reviewed

R Sacco, H C Diener and S Yusuf

Cerebrovascular diseases (Basel, Switzerland), Vol.25(1-2), pp.192-192

2008

PMID: 18416019

Abstract

Data Interpretation, Statistical

Benzoates - therapeutic use

Ticlopidine - therapeutic use

Angiotensin II Type 1 Receptor Blockers - therapeutic use

Humans

Ticlopidine - analogs & derivatives

Drug Interactions

Angiotensin-Converting Enzyme Inhibitors - therapeutic use

Aspirin, Dipyridamole Drug Combination

Aspirin - therapeutic use

Platelet Aggregation Inhibitors - therapeutic use

Delayed-Action Preparations

Dipyridamole - therapeutic use

Drug Combinations

Benzimidazoles - therapeutic use

8 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.71 Cardiology - Circulation; 1.71.193 Acute Myocardial Infarction
Web Of Science research areas: Clinical Neurology; Peripheral Vascular Disease
ESI research areas: Neuroscience & Behavior

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Correction to the PRoFESS Trial paper by Diener et al. (Cerebrovasc Dis 2007;23:368-80
Creators: R Sacco
H C Diener
S Yusuf
Publication Details: Cerebrovascular diseases (Basel, Switzerland), Vol.25(1-2), pp.192-192
Publisher: Switzerland
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Department of Neurology
Language: English
Resource Type: Journal article
PMID: 18416019
Record Identifier: 991031562204202976